OTC · CIK 0001175680
CYDY CytoDyn Inc.
Insider trading from SEC Form 4. Last filing May 22, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Signals
Open-market buys and sells at CytoDyn Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 8 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | Robert E. Hoffman Chief Financial Officer | AGrant or award Non-qualified stock option (right to buy)derivative | +1,000,000 | $0.00 | $0 | 1,000,000 | May 22, 2025 |
| Oct 28, 2024 | Tyler Blok Chief Legal Officer | AGrant or award Non-qualified stock option (right to buy)derivative | +1,250,000 | $0.00 | $0 | 1,250,000 | Oct 30, 2024 |
| Oct 28, 2024 | Karen J Brunke director | AGrant or award Non-qualified stock option (right to buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Oct 30, 2024 |
| Oct 28, 2024 | Ryan Dunlap director | AGrant or award Non-qualified stock option (right to buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Oct 30, 2024 |
| Oct 28, 2024 | Jacob P Lalezari Chief Executive Officer | AGrant or award Non-qualified stock option (right to buy)derivative | +3,000,000 | $0.00 | $0 | 3,000,000 | Oct 30, 2024 |
| Oct 28, 2024 | Lishomwa C Ndhlovu director | AGrant or award Non-qualified stock option (right to buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Oct 30, 2024 |
| Oct 28, 2024 | Stephen M Simes director | AGrant or award Non-qualified stock option (right to buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Oct 30, 2024 |
| Oct 28, 2024 | Tanya Durkee Urbach director | AGrant or award Non-qualified stock option (right to buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Oct 30, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Tyler BlokChief Legal Officer
- Karen J Brunkedirector
- Ryan Dunlapdirector
- Robert E. HoffmanChief Financial Officer
- Jacob P LalezariChief Executive Officer
- Lishomwa C Ndhlovudirector
- Stephen M Simesdirector
- Tanya Durkee Urbachdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.